Skip to main content

Table 1 BOCOMO study schedule of data collection

From: A randomized controlled trial of long term effect of BCM guided fluid management in MHD patients (BOCOMO study): rationales and study design

Item Baseline frequency Follow up frequency
Demographic information Once -
ESRD history1 Once -
Comorbidity2 Once -
Physical examination3 Once Every 2 months
Timed urine collection4 Once Every 2 months
CBC5 Once Every 3 months
Routine laboratory data6 Once Every 3 months
Kt/V Once Every 3 months
iPTH Once Every 3 months
hsCRP Once Every 3 months
UCG Once Every 12 months
BCM measurement Once Every 2 months in BCM arm
Dialysis prescription change7 Once Throughout the study period
Medication change8 Once Throughout the study period
New clinical event9 - Throughout the study period
  1. Abbreviation: BOCOMO study, body composition monitor study; ESRD, end stage renal disease; CBC, complete blood count; Kt/V, calculated using Daugirdas single pool equation; iPTH, intact parathyroid hormone; hsCRP, high sensitive C-reactive protein; UCG, ultrasonic cardiograph.
  2. 1ESRD history includes cause of ESRD, date of first dialysis, type of vascular access.
  3. 2Detailed history of comorbidity will be assessed, including vascular access events.
  4. 3Physical examination includes body weight, blood pressure, heart rate, edema, pulmonary rale, before and after hemodialysis session.
  5. 424 hours urine volume collected the day before dialysis session will be recorded.
  6. 5Consists of hemoglobin, white blood cell count, platelet count.
  7. 6Consists of albumin, pre-Albumin, creatinine, urea, potassium, sodium, chloride, calcium, phosphate, bicarbonate, alkaline phosphatase (ALP), glucose, triglycerides, total cholesterol, low density lipoprotein, high density lipoprotein, brain natriuretic peptide (BNP).
  8. 7Any dialysis prescription change throughout the study period will be recorded.
  9. 8Any medication change throughout the study period will be recorded.
  10. 9Any new clinical event throughout the study period will be recorded, including hospitalization, new diagnosis, vascular access related event, treatment of abnormal laboratory value, dry weight adjustment.